Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
暂无分享,去创建一个
R. Lipton | W. Stewart | Seymour Diamond | Richard B. Lipton | S. Diamond | Walter F. Stewart | Merle L. Diamond | Michael Reed | M. Reed | M. Diamond
[1] Eric R. Ziegel,et al. Generalized Linear Models , 2002, Technometrics.
[2] W F Stewart,et al. Migraine Diagnosis and Treatment: Results From the American Migraine Study II , 2001, Headache.
[3] S. Silberstein. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) , 2000, Neurology.
[4] A. Batenhorst,et al. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. , 2000, Mayo Clinic proceedings.
[5] S. McDonnell,et al. Increasing incidence of medically recognized migraine headache in a United States population. , 1999, Neurology.
[6] R. Lipton,et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score , 1999, Neurology.
[7] Lenore J. Launer,et al. The prevalence and characteristics of migraine in a population-based cohort , 1999, Neurology.
[8] W F Stewart,et al. Burden of migraine in the United States: disability and economic costs. , 1999, Archives of internal medicine.
[9] R. Lipton,et al. Reliability of the Migraine Disability Assessment Score in A Population-Based Sample of Headache Sufferers , 1999, Cephalalgia : an international journal of headache.
[10] R. Lipton,et al. Validity of an illness severity measure for headache in a population sample of migraine sufferers , 1999, PAIN.
[11] P. Goadsby. Advances in the Pharmacotherapy of Migraine , 1999 .
[12] P. Jhingran,et al. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. , 1998, Archives of internal medicine.
[13] R. Lipton,et al. Medical Consultation for Migraine: Results From the American Migraine Study , 1998, Headache.
[14] David P. Miller,et al. Impact of Oral Sumatriptan on Workplace Productivity, Health-Related Quality of Life, Healthcare Use, and Patient Satisfaction with Medication in Nurses with Migraine , 1996 .
[15] R. Lipton,et al. Classification of daily and near-daily headaches , 1996, Neurology.
[16] R. Lipton,et al. Variation in migraine prevalence by race , 1996, Neurology.
[17] D. Gutterman,et al. Impact of Sumatriptan on Workplace Productivity, Nonwork Activities, and Health‐Related Quality of Life Among Hospital Employees With Migraine , 1996, Headache.
[18] B. Sternfeld,et al. Migraine Headache in a Prepaid Health Plan: Ascertainment, Demographics, Physiological, and Behavioral Factors , 1996, Headache.
[19] M. Szklo,et al. Relationship of headache to phase of the menstrual cycle among young women , 1995, Neurology.
[20] W. Stewart,et al. Population variation in migraine prevalence: a meta-analysis. , 1995, Journal of clinical epidemiology.
[21] B. O'brien,et al. Prevalence of migraine headache in Canada: a population-based survey. , 1994, International journal of epidemiology.
[22] B. Martin,et al. Prevalence of migraine headache and association with sex, age, race, and rural/urban residence: a population-based study of Georgia Medicaid recipients. , 1994, Clinical therapeutics.
[23] R. Lipton,et al. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. , 1994, Neurology.
[24] H. Göbel,et al. The Epidemiology of Headache in Germany: A Nationwide Survey of A Representative Sample on The Basis of The Headache Classification of The International Headache Society , 1994, Cephalalgia : an international journal of headache.
[25] P. Stang,et al. Impact of Migraine in the United States: Data from the National Health Interview Survey , 1993, Headache.
[26] R. F. Nelson,et al. A Canadian Population Survey on the Clinical, Epidemiologic and Societal Impact of Migraine and Tension-Type Headache , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[27] J. Dartigues,et al. A Nationwide Survey of Migraine in France: Prevalence and Clinical Features in Adults , 1992, Cephalalgia : an international journal of headache.
[28] R. Lipton,et al. Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. , 1992, Archives of internal medicine.
[29] W. Stewart,et al. Medication Use and Disability Among Migraineurs: A National Probability Sample Survey , 1992, Headache.
[30] P E Shrout,et al. Socioeconomic status and psychiatric disorders: the causation-selection issue. , 1992, Science.
[31] P. Kero,et al. Prevalence of Headache at Preschool Age in An Unselected Child Population , 1991, Cephalalgia : an international journal of headache.
[32] M. Zimmermann,et al. Epidemiology of pain , 1990, Pain.
[33] Giuseppe Orefice,et al. Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study , 1988, Cephalalgia : an international journal of headache.
[34] J. Owen. Physiology of the menstrual cycle. , 1975, The American journal of clinical nutrition.
[35] P. Goadsby. Advances in the pharmacotherapy of migraine. How knowledge of pathophysiology is guiding drug development. , 1999, Drugs in R&D.
[36] P. Borgiani,et al. Both maternal and foetal genetic factors contribute to macrosomia of diabetic pregnancy. , 1994, Human heredity.
[37] W F Stewart,et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. , 1992, JAMA.
[38] Prevalence of chronic migraine headaches--United States, 1980-1989. , 1991, MMWR. Morbidity and mortality weekly report.
[39] Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. , 1988, Cephalalgia : an international journal of headache.